Topic Review
Trauma-Related Thoracic Outlet Syndrome
Thoracic outlet syndrome (TOS) is a group of symptoms that result from compression of the neurovascular bundle that exits the thoracic outlet. The thoracic outlet is defined as an anatomical area in the lower neck, extended from the supraclavicular fossa to the axilla, and consists of three main spaces, the interscalene triangle, the costoclavicular, and the subcoracoid space. These confined spaces go through relevant structures, which include the subclavian and axillary arteries, their venous counterparts, and the brachial plexus (BP).
  • 181
  • 07 Nov 2023
Topic Review
Oncolytic Virotherapy for Head and Neck Cancer
Head and neck cancer (HNC) is a significant global health issue, and traditional treatments such as surgery, chemotherapy, and radiation therapy often have limited success, especially in advanced cases. Oncolytic virotherapy (OVT) offers a new approach.
  • 208
  • 06 Nov 2023
Topic Review
Lupus Anticoagulant Detection under Magnifying Glass
Diagnosis of antiphospholipid syndrome (APS) requires the presence of a clinical criterion (thrombosis and/or pregnancy morbidity), combined with persistently circulating antiphospholipid antibodies (aPL). Lupus anticoagulant (LA) is one of the three laboratory parameters (the others being antibodies to either cardiolipin or β2-glycoprotein I) that defines this rare but potentially devastating condition. For the search for aCL and aβ2-GP-I, traditionally measured with immunological solid-phase assays (ELISA), several different assays and detection techniques are available, thus making these tests relatively reliable and widespread. On the other hand, LA detection is based on functional coagulation procedures that are characterized by poor standardization, difficulties in interpreting the results, and interference by several drugs commonly used in the clinical settings in which LA search is appropriate. 
  • 124
  • 06 Nov 2023
Topic Review
Bone Tissue Microenvironment in Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL) is the most frequent leukemia in Western countries. Although characterized by the progressive expansion and accumulation of leukemic B cells in peripheral blood, CLL cells develop in protective niches mainly located within lymph nodes and bone marrow. Multiple interactions between CLL and microenvironmental cells may favor the expansion of  the malignant B cell clone, further driving immune cells toward an immunosuppressive phenotype. In addition the active crosstalk between leukemic B cells and bone tissue microenvironments may lead to the alteration of bone homeostasis in CLL patients.
  • 286
  • 06 Nov 2023
Topic Review
Nanotechnology-Based Drug Delivery to Control Bacterial-Biofilm-Associated Lung Infections
Airway mucus dysfunction and impaired immunological defenses are hallmarks of several lung diseases, including asthma, cystic fibrosis, and chronic obstructive pulmonary diseases, and are mostly causative factors in bacterial-biofilm-associated respiratory tract infections. To combat bacterial biofilm in the respiratory tract, researchers have developed various strategies, including a pipeline of new antibiotics, biofilm biomatrix disruption, quorum sensing inhibition, biofilm dispersion promotion, or combinations of these. Among the strategies, nanoparticle-based drug delivery systems have received increasing attention for delivering antibiotics to biofilm sites or enhancing anti-biofilm activity through the nanoparticles themselves. 
  • 342
  • 06 Nov 2023
Topic Review
Apolipoprotein D in Neuropsychiatric Disorders
Neuropsychiatric disorders (NDs) are a diverse group of pathologies, including schizophrenia or bipolar disorders, that directly affect the mental and physical health of those who suffer from them, with an incidence that is increasing worldwide. Most NDs result from a complex interaction of multiple genes and environmental factors such as stress or traumatic events, including the recent Coronavirus Disease (COVID-19) pandemic.
  • 420
  • 06 Nov 2023
Topic Review
Thromboembolic and Bleeding Events in Transthyretin Amyloidosis
Transthyretin amyloidosis (ATTR) is a group of diseases caused by the deposition of insoluble fibrils derived from misfolded transthyretin, which compromises the structure and function of various organs, including the heart. Thromboembolic events and increased bleeding risk are among the most important complications of ATTR, though the underlying mechanisms are not yet fully understood. Transthyretin plays a complex role in the coagulation cascade, contributing to the activation and regulation of the coagulation and fibrinolytic systems. The prevalence of atrial fibrillation, cardiac mechanical dysfunction, and atrial myopathy in patients with ATTR may contribute to thrombosis, though such events may also occur in patients with a normal sinus rhythm and rarely in properly anticoagulated patients. Haemorrhagic events are modest and mainly linked to perivascular amyloid deposits with consequent capillary fragility and coagulation anomalies, such as labile international-normalised ratio during anticoagulant therapy. 
  • 286
  • 06 Nov 2023
Topic Review
Immunotherapy of Keloids
Keloids are benign fibroproliferative tumors originating from abnormal wound healing. Many factors can cause keloids, including trauma, surgery, burns, vaccination, acne, and folliculitis, which can be summarized as dermal injury and irritation, in general. However, superficial injuries that do not reach the reticular dermis will not cause keloids, suggesting that keloids result from injury to this skin layer and subsequent abnormal wound healing.
  • 313
  • 06 Nov 2023
Topic Review
Risk Factors for Systemic Sclerosis–Associated Interstitial Lung Disease
Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by immune dysregulation and progressive fibrosis, typically affecting the skin, with variable internal organ involvement. Interstitial lung disease (ILD), with a prevalence between 35 and 75%, is the leading cause of death in patients with SSc, indicating that all newly diagnosed patients should be screened for this complication. Some patients with SSc-ILD experience a progressive phenotype, which is characterized by worsening fibrosis on high-resolution computed tomography (HRCT), a decline in lung function, and premature mortality. To assess progression and guide therapeutic decisions, regular monitoring is essential and should include pulmonary function testing (PFT), symptom assessment, and repeat HRCT imaging when indicated. Multidisciplinary discussion allows a comprehensive evaluation of the available information and its consequences for management. There has been a shift in the approach to managing SSc-ILD, which includes the addition of targeted biologic and antifibrotic therapies to standard immunosuppressive therapy (particularly mycophenolate mofetil or cyclophosphamide), with autologous hematopoietic stem-cell transplantation and lung transplantation reserved for refractory cases.
  • 418
  • 06 Nov 2023
Topic Review
Artificial Intelligence in Polyp Detection
There has been an exponential rise in the availability of artificial intelligence systems in endoscopy. As a result, maintaining an informed understanding of the utility and efficacy of existing systems has become increasingly complex. 
  • 179
  • 06 Nov 2023
  • Page
  • of
  • 1349
Video Production Service